John C. Drescher is Executive Director of TechNet Northwest, based in Seattle. Patrick J. Ennis has 25 years of experience turning technologies into products.
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars